Press Releases

Varian to Attend Upcoming Investor Events

Varian (NYSE: VAR) today announced that it will be attending the UBS Global Healthcare Conference (May 20-22) and the 2019 RBC Capital Markets Healthcare Conference (May 21-22) in New York City....

South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System

Varian (NYSE: VAR) announced Groote Schuur Hospital in Cape Town, South Africa is the first hospital in Africa to deliver High Dose Rate (HDR) brachytherapy treatments with the Bravos™...

Ofuna Chuo Hospital Delivers First Varian Halcyon System Treatments in Japan

Varian (NYSE: VAR) today announced Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture, Japan is the first clinic in the country to begin treating cancer patients using the Halcyon™...

Varian Announces Global Clinical Consortium to Develop Evidence-based Protocols for Adaptive Radiotherapy

Bringing together a global community of clinicians and scientists from leading cancer clinics to develop best practices for adaptive radiotherapy based on clinical evidence, Varian (NYSE: VAR)...

Varian Reports Results for Second Quarter of Fiscal Year 2019

Second Quarter 2019 Summary – Oncology gross orders grew 15% in dollars, or 18% in constant currency – Total company revenues grew 7% in dollars, or 10% in constant currency, to $779 million...

First Varian Halcyon Treatments in Kenya Begin at Nairobi West Hospital

Varian (NYSE: VAR) today announced that The Nairobi West Hospital in Nairobi, Kenya is the first clinic in the country and in West, Central, and East Africa to begin treating cancer patients using...

Varian to Demonstrate Advanced Cancer Care Solutions at ESTRO 38

Varian (NYSE: VAR) today announced it will be showcasing its new single-room proton therapy system, ProBeam® 360°, and the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy...

Varian Installs Cyclotron for ProBeam Proton Therapy System at Hefei Ion Medical Center in China

Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® proton therapy system at Hefei Ion Medical Center (HIMC) in China. The cyclotron is a core piece of...

Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment

At the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, GA, Varian (NYSE: VAR), in partnership with the University of Maryland School of Medicine's Department of...

Varian Opens Office in South Africa to Support Regional Growth

At a grand opening ceremony held March 8th, the Varian office in Hertford Office Park, Midrand, Johannesburg, South Africa was officially inaugurated. Prior to the opening of the permanent...